Physician

Adam Michael Schindelheim, M.D.

According to 2025 Medicare claims, Adam Schindelheim, M.D. (NPI: 1003961368) practices physical medicine and rehabilitation in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is COOPER PHYSICAL MEDICINE & REHABILITATION ASSOCIATES, PC (NPI: 1508808221; TIN: 223137520) and primary practice location at 08102-1029.

Schindelheim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 515 traditional Medicare patients, billed 6,830 HCPCS/CPT codes, and received $185,155 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 553 prescription claims across 64 beneficiaries totaling $37,317 in drug costs, led by Oxycontin (Oxycodone Hcl). DME data shows 11 claims. Open Payments data shows 5 records totaling $194. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,376 to $818.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	980	4,321	$197,040
2016	792	3,304	$153,356
2017	659	2,133	$140,872
2018	601	2,435	$142,325
2019	575	3,243	$156,635
2020	476	1,552	$90,953
2021	564	2,647	$144,395
2022	606	3,405	$178,602
2023	613	4,969	$205,567
2024	515	6,830	$185,155

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	387	$51,710
2016	81	383	$38,238
2017	61	419	$36,652
2018	32	331	$28,898
2019	43	336	$27,663
2020	33	297	$22,728
2021	52	398	$24,409
2022	46	457	$32,021
2023	57	480	$41,725
2024	64	553	$37,317

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$274
2016	N/R	24	$312
2017	N/R	129	$1,904
2018	N/R	165	$2,142
2019	N/R	15	$166
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$818

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	70	71	$110
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	45	46	$72
99304	Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	175	182	$69
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	231	1,602	$66
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	81	107	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	32	956	$17,459
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	100	3,000	$2,024
Oxycodone Hcl	Oxycodone Hcl	97	2,877	$1,617
Fentanyl	Fentanyl	24	720	$1,459
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	411	$667

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	11	$818

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$194	Merz Pharmaceuticals, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Michael Schindelheim, M.D.?

Tedicare shows public-source Medicare data for Adam Michael Schindelheim, M.D. (NPI 1003961368), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Michael Schindelheim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Michael Schindelheim, M.D.?

Adam Michael Schindelheim, M.D. is linked to COOPER PHYSICAL MEDICINE & REHABILITATION ASSOCIATES, PC (billing NPI 1508808221) in the available physician profile data.

Does Adam Michael Schindelheim, M.D. have Open Payments data?

Adam Michael Schindelheim, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.